GILEAD SCIENCES, INC.

Biological Products, (No Diagnostic Substances)·FOSTER CITY, CA·FY end 12/31·CIK 882095

Board of Directors

9 members · 8 independent · FY 2025

Director	Role	Tenure	Age	Committees	Indep.	Annual fees
Jacqueline K. Barton, Ph.D.	Director	8y	73	CompScience		—
Jeffrey A. Bluestone, Ph.D.	Director	6y	72	Science		—
Sandra J. Horning, M.D.	Director	6y	77	NCGScience		—
Kelly A. Kramer	Director	10y	58	AuditComp		—
Ted W. Love, M.D.	Director	2y	67	Audit		—
Harish Manwani	Director	8y	72	CompNCG		—
Daniel P. O'Day	CEO and Director	7y	61	—	—	—
Javier J. Rodriguez	Director	6y	55	Audit		—
Anthony Welters	Lead Independent Director	6y	71	CompNCG		—

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.